Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of Sepsis

This publication has 58 references indexed in Scilit:

• Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries
  American Journal of Hematology, 1998
• ANIMAL MODELS OF SEPSIS AND SHOCK
  Shock, 1998
• Inhibition of Tissue Factor and Cytokine Release
  Pathophysiology of Haemostasis and Thrombosis, 1996
• Characterization of the Murine Plasma Fibrinolytic System
  European Journal of Biochemistry, 1994
• Multiple Organ Failure Pathophysiology and Potential Future Therapy
  Annals of Surgery, 1992
• C5a-mediated release of interleukin 6 by human monocytes
  Clinical Immunology and Immunopathology, 1990
• The Role of Plasma Proteases in Septic Shock
  New England Journal of Medicine, 1989
• C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.
  The Journal of Experimental Medicine, 1988
• Cultured human endothelial cells generate tissue factor in response to endotoxin.
  Journal of Clinical Investigation, 1983
• Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors.
  The Journal of Experimental Medicine, 1982